RespireRx Pharmaceuticals Inc.

(RSPI)

By |

Profile

RespireRx Pharmaceuticals Inc focuses on developing drug candidates to treat respiration-related markets that are unserved or poorly served. It is engaged in the development of pharmaceuticals for the treatment of neurological and psychiatric disorders.

Contact Information

Website: www.respirerx.com
Main Phone: +1 201 444-4947
Address: 126 Valley Road
Address 2: Suite C
State: NJ
City / Town: Glen Rock
Country: USA
Postal Code: 07452

Issuer Information

Exchange: OTCQB
CEO: Mark A. Varney
Employees: 4
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 0.90 $ 0. (0.00%)
Last Price 0.90 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close 0.90
Last Trade Volume 69 52 Wk Hi 2.90 52 Wk Low 0.40
Market Cap 2.8 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 3,123,332.00 EPS (TTM) -1.35 PE Ratio N/A Exchange OTCQB
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 4.5 4.5 4.5 4.5
Low Target Price Estimate 0.3 0.3 0.3 0.3
Mean Target Price Estimate 2.4 2.4 2.4 2.4
Standard Deviation 2.97 2.97 2.97 2.97
Date of Most Recent Estimate 10/11/07 10/11/07 10/11/07 10/11/07
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 0 0 0 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 3